ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
This Quarter Return
-10.74%
1 Year Return
-8.06%
3 Year Return
+35.07%
5 Year Return
+60.97%
10 Year Return
–
AUM
$389M
AUM Growth
+$389M
(-14%)
Cap. Flow
-$3.91M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
441
New
20
Increased
71
Reduced
74
Closed
17
Top Buys
| 1 |
Amazon
AMZN
|
$5.95M |
| 2 |
Freeport-McMoran
FCX
|
$1.89M |
| 3 |
Okta
OKTA
|
$518K |
| 4 |
Charles Schwab
SCHW
|
$471K |
| 5 |
Adobe
ADBE
|
$461K |
Top Sells
| 1 |
Dover
DOV
|
$333K |
| 2 |
Church & Dwight Co
CHD
|
$306K |
| 3 |
Bristol-Myers Squibb
BMY
|
$279K |
| 4 |
iShares Gold Trust
IAU
|
$255K |
| 5 |
ResMed
RMD
|
$199K |
Sector Composition
| 1 | Technology | 23.48% |
| 2 | Healthcare | 14.39% |
| 3 | Consumer Staples | 13.42% |
| 4 | Financials | 11.87% |
| 5 | Energy | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novartis
NVS
$245B
| $4.36M | 1.12% | 51,602 -816 | -2% | -$69K |
|
27
Philip Morris
PM
$260B
| $4.16M | 1.07% | 42,162 +34 | +0.1% | +$3.36K |
|
28
Weyerhaeuser
WY
$18.7B
| $3.85M | 0.99% | 116,310 +4,315 | +4% | +$143K |
|
29
Altria Group
MO
$113B
| $3.79M | 0.97% | 90,651 -271 | -0.3% | -$11.3K |
|
30
Stock Yards Bancorp
SYBT
$2.38B
| $3.77M | 0.97% | 63,043 +82 | +0.1% | +$4.91K |
|
31
McCormick & Company Non-Voting
MKC
$18.9B
| $3.68M | 0.95% | 44,247 +267 | +0.6% | +$22.2K |
|
32
Alphabet (Google) Class C
GOOG
$2.58T
| $3.51M | 0.9% | 1,603 +2 | +0.1% | +$4.38K |
|
33
PayPal
PYPL
$67.1B
| $3.34M | 0.86% | 47,823 +2,883 | +6% | +$201K |
|
34
Coca-Cola
KO
$297B
| $3.32M | 0.85% | 52,841 -423 | -0.8% | -$26.6K |
|
35
Automatic Data Processing
ADP
$123B
| $3.31M | 0.85% | 15,742 -90 | -0.6% | -$18.9K |
|
36
HCI Group
HCI
$2.16B
| $3.02M | 0.78% | 44,559 -737 | -2% | -$49.9K |
|
37
Estee Lauder
EL
$33B
| $2.9M | 0.75% | 11,393 -235 | -2% | -$59.9K |
|
|
38
ResMed
RMD
$40.2B
| $2.87M | 0.74% | 13,683 -950 | -6% | -$199K |
|
39
Toronto Dominion Bank
TD
$128B
| $2.85M | 0.73% | 43,504 | – | – |
|
40
Edwards Lifesciences
EW
$47.8B
| $2.75M | 0.71% | 28,926 +1,220 | +4% | +$116K |
|
41
Novo Nordisk
NVO
$251B
| $2.74M | 0.7% | 24,587 +87 | +0.4% | +$9.7K |
|
42
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.68M | 0.69% | 9,810 -50 | -0.5% | -$13.6K |
|
43
Seacoast Banking Corp of Florida
SBCF
$2.73B
| $2.64M | 0.68% | 79,847 -2,280 | -3% | -$75.3K |
|
44
Vertex Pharmaceuticals
VRTX
$100B
| $2.62M | 0.67% | 9,312 -218 | -2% | -$61.4K |
|
45
TC Energy
TRP
$54.1B
| $2.6M | 0.67% | 50,125 -1,100 | -2% | -$57K |
|
46
Roper Technologies
ROP
$56.6B
| $2.56M | 0.66% | 6,487 +242 | +4% | +$95.5K |
|
47
Hingham Institution for Saving
HIFS
$620M
| $2.51M | 0.65% | 8,847 +122 | +1% | +$34.6K |
|
48
Stryker
SYK
$150B
| $2.33M | 0.6% | 11,695 -530 | -4% | -$105K |
|
|
49
Okta
OKTA
$16.4B
| $2.3M | 0.59% | 25,450 +5,729 | +29% | +$518K |
|
50
Gilead Sciences
GILD
$140B
| $2.29M | 0.59% | 36,992 -961 | -3% | -$59.4K |
|